Welcome to our dedicated page for Bleichroeder Acquisition SEC filings (Ticker: BACQU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SPAC disclosures are often a maze of trust-account figures, warrant conversions and last-minute 8-K merger announcements. Bleichroeder Acquisition Corp (BACQU) is no exception, and piecing together what matters in each filing can feel overwhelming.
Stock Titan solves that problem. Our AI reads every Bleichroeder Acquisition Corp SEC filing the moment it hits EDGAR, turns the legal language into plain-English highlights and tags the data investors hunt for: cash held in trust, extension vote deadlines, sponsor promote terms and any red-flag amendments. Whether you need a quick rundown of the Bleichroeder Acquisition Corp annual report 10-K simplified or want instant alerts on Bleichroeder Acquisition Corp insider trading Form 4 transactions, the platform delivers clarity in seconds.
All filing types are covered in real time:
- Form 8-K material events explained the day a merger LOI is signed
- Bleichroeder Acquisition Corp quarterly earnings report 10-Q filing with AI-driven variance analysis
- Bleichroeder Acquisition Corp Form 4 insider transactions real-time to track sponsor and executive moves
- Proxy statement executive compensation details before the combination vote
Use cases range from monitoring Bleichroeder Acquisition Corp executive stock transactions Form 4 ahead of redemption deadlines to comparing trust interest income across quarters. If you’re understanding Bleichroeder Acquisition Corp SEC documents with AI for the first time, or you need a deeper Bleichroeder Acquisition Corp earnings report filing analysis, our expert layer surfaces what drives valuation so you can act decisively. No more scrolling through hundreds of pages—critical SPAC insights are already distilled for you.
VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.
Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (≈0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.
FAQ
What is the current stock price of Bleichroeder Acquisition (BACQU)?
What is a blank check company?
How does Bleichroeder Acquisition Corp generate value?
What are the main components of the company’s units?
How does the trust account mechanism work?
What type of companies might be targeted for a business combination?
How is the regulatory environment managed?
What are the risks associated with investing in a SPAC?
How does BACQU differentiate itself from its competitors?
